Related Experiment Video
Updated: May 22, 2026
03:47
Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
Published on: July 12, 2024
Rationale and Design of the Türkiye Heart Failure (TURK-HF) Registry
Umut Kocabas1, Selda Murat2, Tarık Kıvrak3
1Department of Cardiology, Başkent University Izmir Hospital, Izmir, Türkiye.
Clinical Cardiology
|May 21, 2026
Summary
The Türkiye Heart Failure (TURK-HF) registry is a national study examining heart failure (HF) patient characteristics, treatments, and outcomes in Türkiye. It aims to improve evidence-based HF therapy implementation.
Area of Science:
- Cardiology
- Public Health
- Clinical Research
Background:
- Heart failure (HF) is a significant public health concern globally and in Türkiye.
- Understanding the specific characteristics and management of HF patients in Türkiye is crucial for improving care.
- Existing data on HF in Türkiye may not fully represent the diverse patient population and current treatment landscape.
Purpose of the Study:
- To characterize the sociodemographic and clinical profiles of heart failure patients in Türkiye.
- To evaluate current management strategies and the implementation of evidence-based therapies for heart failure.
- To assess the clinical outcomes, including mortality and hospitalizations, of patients with heart failure in Türkiye.
Main Methods:
- A national, multicenter, prospective, observational study involving 46 investigators from 38 centers across Türkiye.
- Inclusion of unselected patients with heart failure (HF) irrespective of ejection fraction.
- Comprehensive baseline data collection including sociodemographics, medical history, comorbidities, frailty, quality of life, diagnostic data, and therapies; systematic documentation of acute HF hospitalizations and 6-month follow-up.
Main Results:
- The TURK-HF registry provides a detailed, real-world snapshot of heart failure patient profiles in Türkiye.
- It systematically documents management strategies and adherence to evidence-based HF therapies.
- The study collects comprehensive data on clinical endpoints such as mortality, HF-related hospitalizations, and patient-reported outcomes.
Conclusions:
- The TURK-HF registry yields valuable insights into contemporary heart failure care in Türkiye.
- Findings have the potential to inform and refine HF management strategies and clinical research.
- The registry can guide public health policies aimed at improving heart failure outcomes in Türkiye.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...